FDA accepts PaxVax oral cholera vaccine IND application
PXVX-0200 is a live attenuated vaccine against cholera, which was previously approved and marketed in six countries under the brand name Orochol. The company expects to begin Phase
The US Food and Drug Administration (FDA) has granted priority review to Roche’s supplemental biologics licence application (sBLA) for Gazyva/Gazyvaro (obinutuzumab) to treat adults with primary membranous nephropathy (pMN).